PM H-Regulator

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Glycine max, Quantity: 200 mg (Equivalent: Glycine max, Qty 32 g; Equivalent: isoflavones calc daidzin/ein, genistin/ein, glycitin/ein (Glycine max), Qty 80 mg); Vitex agnus-castus, Quantity: 20 mg (Equivalent: Vitex agnus-castus, Qty 200 mg)

Available from:

Pharmametics Products A Division of Max Biocare Pty Ltd

INN (International Name):

Glycine max,Vitex agnus-castus

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: sunset yellow FCF; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; Gelatin; pregelatinised maize starch; erythrosine; microcrystalline cellulose; sodium lauryl sulfate; potable water; titanium dioxide; magnesium stearate

Administration route:

Oral

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body ; Helps enhance/promote general health and wellbeing ; Maintain/support bone health ; Help maintain/support bone mineralisation ; Maintain/support cardiovascular system health ; Maintain/support female healthy hormonal balance ; Maintain/support female healthy hormonal balance during the reproductive cycle ; Decrease/reduce/relieve menstrual cycle irregularity/irregular periods ; Maintain/support/regulate healthy menstrual cycle ; Decrease/reduce/relieve menstrual spasms/cramps ; Decrease/reduce/relieve menstruation pain/dysmenorrhoea ; Decrease/reduce/relieve breast pain/tenderness associated with premenstrual tension ; Maintain/support healthy female hormonal balance during menopause ; Helps decrease/reduce/relieve night sweats associated with menopause ; Decrease/reduce/relieve symptoms of menopause ; Helps reduce occurrence of menopausal symptoms ; Decrease/reduce/relieve hot flushes associated with menopause ; Decrease/reduce/relieve aggression/irritability associated with menopause ; Helps reduce occurrence of symptoms of acne

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2008-10-20